SYNOPSIS
There are three key issues relating anemia and transfusion: 1) anemia may be well tolerated by patients with physiologic reserve, 2) donor red blood cell physiology is impaired compared to that for native red blood cells, and 3) patients transfused for indications other than anemia attributable oxygen delivery failure have worse outcomes than those who are not transfused. Current approaches to transfusion decision-making (TDM) lack the ability to: 1) differentiate between patients who require transfusions and those that do not and 2) guide transfusion timing and amount based upon oxygen delivery-based targets. This review explores approaches to TDM and how continued advances are leading to a revolution in the field of transfusion medicine itself.